Children born during the pandemic, including those exposed to COVID-19 in utero, were no more likely to screen positive for autism than unexposed or pre-pandemic children.
The 2024 Lasker-Bloomberg Public Service Award recognizes Quarraisha Abdool Karim and Salim S. Abdool Karim for global contributions to the fight against HIV/AIDS.
A new study reveals how Staphylococcus aureus bacteria adopt a different diet when colonizing the lungs, suggesting a new treatment strategy for these often dangerous staph infections.
Researchers from the NIH RECOVER Initiative have identified long COVID symptoms in kids and teens, which could ultimately lead to improved diagnoses and treatments for millions.
A 15-minute COVID-19 test that can be used at home to identify infectious people is under development in David Ho’s laboratory and has received support from the NYC Economic Development Corporation.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.
People who took statins to lower cholesterol were about 50% less likely to die if hospitalized for COVID-19, a retrospective study by Columbia University and NewYork-Presbyterian physicians has found.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
A nasal spray created by Columbia researchers prevented transmission of SARS-CoV-2 in ferrets, suggesting the spray could also prevent transmission of the coronavirus in people.
Since the beginning of the pandemic, more than 120 million people in the United States may have been infected by SARS-CoV-2, according to researchers at the Mailman School of Public Health.
Pregnant women face greater risks to their health from COVID-19 than the general population and should be offered a vaccine if eligible, say experts at Columbia and NewYork-Presbyterian.
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.